Goodwin advised LFPI on its acquisition of a minority stake. LFPI, one of the leading independent ESG multi-strategy asset managers in Europe and the United States,...
LFPI’s Acquisition of a Minority Stake in Tikamoon
Marlin Equity’s Acquisition of Meltwater N.V.
AKD, Wiersholm, Houthoff, Schjødt, DLA Piper and Goodwin Procter advised Marlin Equity Partners on the deal, while Freshfields and Thomessen acted for Altor. Marlin Equity Partners,...
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
ITEN’s €80 Million Fundraising
Chammas & Marcheteau advised SEB Alliance on the transaction. Goodwin Paris advised ITEN. UGGC Avocats advised Bpifrance. ITEN, the French specialist in Li-ion ceramic technology, announced its...
Moka.care’s €15 Million Series A Financing
Goodwin Procter advised Left Lane Capital on the deal. Left Lane Capital announced the €15 million Series A financing of Moka.care, a French startup that focuses on...
Umiami’s €26.5 Million Series A Financing
Goodwin advised Umiami on the deal. Umiami, a French foodtech startup specializing in 100% plant-based poultry fillets, announced its €26.5 million Series A financing. The fundraising was...
Interflora’s Sale of Renaud Distribution
IN BRIEF: Goodwin Procter, advised on the matter. Goodwin Procter advised Interflora with a team including Maxence Bloch (Picture – Corporate M&A). Read the full article...
Genfit’s Licensing Agreement with Genoscience Pharma
Goodwin Procter advised Genfit on the deal. Genfit entered into a licensing agreement with Genoscience Pharma for exclusive right to develop and commercialize the investigational treatment...
Left Lane Capital’s €3.7 Million Fund Raising into MentorShow
Goodwin Procter LLP advised Left Lane Capital on the deal. Left Lane Capital led an approximately €3.7 million fund raising (Series A) into MentorShow, a French online...